Medicare is
looking for ways to lower its costs, and has revisited fee schedules for
several categories of services. Regarding medical supplies and DME, they
have decided to use competitive bidding in order to extract lower prices
from its service providers. To a certain extent this allows market
forces to determine pricing for medical supplies. Competitive bidding
would allow the Health Care Financing Administration, or HCFA, to
contract with specific providers to deliver goods and services to
Medicare beneficiaries in specific geographic areas—at a fixed price.
The Department of Veterans Affairs is able to use competitive bidding,
as are the individual states with their Medicaid programs, and
commercial insurance plans and hospitals, so supporters of competitive
bidding ask “why not Medicare”?[1]
Since 1989, Medicare has paid for medical equipment and
supplies through fee schedules that list maximum and minimum payment
amounts.
The schedules are based on average supplier charges on
Medicare claims from 1986 and 1987 and have been updated to reflect
inflation.
However, they feels this payment approach lacks the
necessary flexibility to keep pace with market changes, and as a result,
often pays higher prices than other public payers for medical equipment
and supplies.
The Balanced Budget Act of 1997 (BBA) required CMS to
test competitive bidding as a new way for Medicare to set fees for Part
B items and services specified by CMS, (which was accomplished through a
demonstration project focused on medical equipment and supplies). The
estimated savings to Medicare based on the demonstration project were
nearly 25%. About a year after the demonstration concluded, the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003 (MMA)
required CMS to conduct a competitive bidding program for DME, medical
supplies, off-the-shelf orthotics, and enteral nutrients (and related
equipment and supplies) on a large scale.
There are
fears inside Medicare that as competitive bidding expands and suppliers
get more aggressive, inferior products could get substituted, or
loopholes found in the guidelines that would allow suppliers to finesse
the system to their benefit. Providers are concerned that they will lose
money both through lower prices, and the fact that only a certain number
of providers will be allowed to qualify for Medicare’s competitive
bidding program in any one area, leaving the rest of the suppliers to
make up the lost revenue elsewhere.
CMS has plans to expand their monitoring of the program
through beneficiary satisfaction surveys, so that beneficiaries and
providers alike are protected.[2]
The Round 1 rebid will include the following categories
of items and services: Oxygen Supplies and Equipment; Standard Power
Wheelchairs, Scooters, and Related Accessories; Complex Rehabilitative
Power Wheelchairs and Related Accessories (Group 2); Mail-Order
Diabetic Supplies; Enteral Nutrient, Equipment and Supplies; Continuous
Positive Airway Pressure (CPAP); Respiratory Assist Devices (RADs), and
Related Supplies and Accessories; Hospital Beds and Related Accessories:
Walkers and Related Accessories; Support Surfaces (Group 2 mattresses)
and overlays in Miami.
It will be phased in in the nine largest Metropolitan
Statistical Areas (MSAs): Cincinnati – Middletown (OH, KY and IN);
Cleveland –Elyria-Mentor (OH); Charlotte-Gastonia-Concord (NC and SC);
Dallas-Fort Worth-Arlington (TX); Kansas City (MO and KS); Miami- Fort
Lauderdale-Miami Beach (FL); Orland (FL); Pittsburgh (PA); Riverside-San
Bernardino-Ontario (CA).